Massachusetts General Hospital
‘Fast’ MRI shows potential as prostate cancer screening method
MRI improved detection of clinically significant prostate cancer without increasing overdiagnosis compared with PSA testing, according to a prospective, population-based, blinded cohort study published in JAMA Oncology.
Securing reimbursement, broadband access vital for optimizing telehealth
Data indicate that access to telehealth is not universal across the United States, according to a presentation at the American Telemedicine Association EDGE Policy Meeting.
Long-term, regular aspirin use linked to lower colorectal cancer mortality
Long-term, regular use of aspirin before diagnosis appeared associated with lower colorectal cancer-specific mortality, according to results of an observational study published in Journal of the National Cancer Institute.
Evidence suggests patients on low-carb diets achieve type 2 diabetes remission
Patients with diabetes who consistently followed a low-carbohydrate diet for 6 months achieved a higher rate of remission — 32% — compared with mostly low-fat diets, according to a systematic review and meta-analysis.
In acute ischemic stroke, women present with greater severity than men
Women admitted for acute ischemic stroke more often presented with a higher degree of disability and were more likely to undergo intra-arterial thrombolysis compared with men, according to research published in Stroke.
Better understanding of late effects needed to guide survivorship care after CAR-T
Little is known about the long-term issues facing cancer survivors who received chimeric antigen receptor T-cell therapy, primarily because the therapy is relatively new.
Ivosidenib confers clinical benefit in advanced cholangiocarcinoma subset
Ivosidenib modestly extended OS among patients with previously treated isocitrate dehydrogenase 1-mutated advanced cholangiocarcinoma, according to final results of the phase 3 ClarIDHy trial presented at Gastrointestinal Cancers Symposium.
Risks for severe COVID-19 outcomes in patients with rheumatic disease 'remain substantial'
Although the risk for severe COVID-19 outcomes in patients with rheumatic and musculoskeletal disease has lowered, it is nonetheless still significant, according to data published in The Lancet Rheumatology.
Patients with systemic autoimmune rheumatic diseases, COVID-19 at greater risk for VTE
Patients with systemic autoimmune rheumatic diseases and COVID-19 may be at greater risk for hospitalization, ICU admission, acute renal failure and venous thromboembolism, according to data published in Arthritis & Rheumatology.
HF prevention strategies needed in patients with diabetes
Preventive HF strategies must be broadened to target patients with diabetes, according to study findings published in JAMA Cardiology.